Companies / Enzo Biochem Inc
Enzo Biochem Inc
ENZENZBCIK 316253
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | Harbert Management Corp 10% owner | Sell Open-market sale | Common Stock | $940.0K | -200K -3.65% | 5,275,913 | medium |
| Jan 23, 2023 | James G. Wolf 10% owner | Other Derivative conversion | Common Stock, $0.01 par value | $571.8K | +229K +5.99% | 4,043,700 | low |
| Mar 15, 2021 | Harbert Management Corp 10% owner | Sell Open-market sale | Common Stock, $0.01 par value ("Common Stock") | $475.0K | -100K -1.78% | 5,520,681 | medium |
| Mar 16, 2021 | Harbert Management Corp 10% owner | Sell Open-market sale | Common Stock | $453.9K | -100K -1.90% | 5,175,913 | medium |
| Dec 14, 2022 | James G. Wolf 10% owner | Other Derivative conversion | Common Stock, $0.01 par value | $340.5K | +136K +3.83% | 3,696,200 | low |
| Jul 5, 2022 | Radoff Bradley Louis Director | Buy Open-market buy | Common Stock, $0.01 Par Value | $264.0K | +120K +2.95% | 4,182,163 | medium |
| Mar 15, 2021 | Harbert Management Corp 10% owner | Sell Open-market sale | Common Stock | $223.8K | -45K -0.81% | 5,475,913 | medium |
| Dec 15, 2022 | James G. Wolf 10% owner | Other Derivative conversion | Common Stock, $0.01 par value | $212.8K | +85K +2.30% | 3,781,300 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ENZ | common | 294100102 |